Hangzhou Diagens Biotechnology Co Ltd (hkse:02526) Share Price

Company Profile

Business description
Hangzhou Diagens Biotechnology Co Ltd is a medical devices company focusing on developing medical imaging products and services. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping which the company intends to sell in China and globally as a customized computer pre-installed with the software.
Contact
No. 609 Hongfeng Road
Room 101, Building 1
Donghu Sub-district
Linping District, Zhejiang
Hangzhou
CHN
T: +86 4000680888
https://www.diagens.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
182

Recommended

We think the floundering stock price is not reflective of underlying asset value.

Brian Han | 10 April 2026

Near-term cost growth does not change our long-term view.

Shane Ponraj, CFA | 10 April 2026

US stores are struggling, but our investment thesis hinges on the Australian rollout.

Johannes Faul, CFA | 09 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,155.80	34.00	0.37%
CAC 40	8,259.60	13.81	0.17%
DAX 40	23,803.95	3.04	-0.01%
Dow JONES (US)	47,916.57	269.23	-0.56%
FTSE 100	10,600.53	2.95	-0.03%
HKSE	25,893.54	141.14	0.55%
NASDAQ	22,902.89	80.48	0.35%
Nikkei 225	56,924.11	1,028.79	1.84%
NZX 50 Index	13,181.44	92.37	-0.70%
S&P 500	6,816.89	7.77	-0.11%
S&P/ASX 200	8,960.60	36.20	0.41%
SSE Composite Index	3,986.22	20.05	0.51%